Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for pharmaceutical industry professionals · Friday, May 30, 2025 · 817,682,599 Articles · 3+ Million Readers

FDA Grand Rounds – Anti-biofilm Technologies for Enhancing the Safety of Medical Device Surfaces - 05/29/2025


Date:
May 29, 2025
Time:
12:00 p.m. - 1:00 p.m. ET

Speaker 

Jayaleka J. Amarasinghe, Ph.D. 
Microbiologist 
Winchester Engineering and Analytical Center (WEAC)
Office of Specialty Laboratories & Enforcement Support (OSLES)
Office of Chief Scientist (OCS)
Office of the Commissioner (OC)

About the Speaker

Dr. Jayaleka Amarasinghe is a microbiologist at the Winchester Engineering and Analytical Center (WEAC), within Office of Specialty Laboratories & Enforcement Support (OSLES), the Office of the Chief Scientist (OCS), in Winchester, Massachusetts. Since joining the FDA in 2014, she has led pioneering research on characterization of biofilms associated with medical device surfaces, driving efforts to develop innovative, antimicrobial-free strategies aimed at enhancing medical device safety. Dr. Amarasinghe earned her undergraduate degree in Biology from Bay Path University in Longmeadow, Massachusetts, and her Ph.D. in Oral Biology from the University at Buffalo, State University of New York. She also completed a postdoctoral fellowship in Infectious Diseases at the New York State Department of Health. Her work has been crucial in advancing novel approaches to anti-biofilm technologies for medical devices.

About the Presentation

Biofilms are communities of microorganisms encased in extracellular polymeric substances that adhere to surfaces, such as medical devices, contributing to chronic infections. Their resistance to conventional antimicrobials makes biofilms particularly difficult to eradicate, highlighting the urgent need for novel approaches. This presentation explores two innovative technologies evaluated at WEAC/FDA to address biofilms on medical device surfaces: photothermal ablation using gold nanorod coatings and electrical stimulation aimed at disrupting biofilm formation.

Learning Objectives

  1. Define the mechanisms of biofilm formation.
  2. Identify emerging antibiofilm technologies. 
  3. Discuss how electrical stimulation is used to eradicate biofilms formed by nontuberculous mycobacteria (NTM) on medical device surfaces.
  4. Discuss how laser-activated gold nanorod-coated titanium surfaces enable photothermal reduction of S. aureus biofilms.

To Register

After MS Teams Webinar registration, you will receive a link via email to access the live webinar. You must log in with the username and password created when you registered.  Please pre-register at least two days before the event to ensure you receive the access link and outlook invitation for the session. 

For technical assistance please contact: Rakesh.Raghuwanshi@fda.hhs.gov.
 

Powered by EIN Presswire

Distribution channels: Healthcare & Pharmaceuticals Industry

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release